See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Chemical Class · Transcription Factors

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
13492 Androgen Receptor (Phospho-Ser210,213) Monoclonal Antibody (Clone 156C135.2) - 2009-08-27 3.204696132596 androgen-receptor-phospho-ser210-213-monoclonal-antibody-clone-156c135-2 AR WB western blots immunoblotting IHC immunohistochemistry paraffin receptors signaling pathway blotting 3.204696132596
10009410 ATF2 (Phospho-Ser490,498) Polyclonal Antibody - 2006-11-28 0.870165745856 atf2-phospho-ser490-498-polyclonal-antibody Activating Transcription Factor 2 wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting 0.870165745856
600130 ATF2 (Phospho-Thr69,71) Transcription Factor Assay Kit - 2009-11-11 21.891220492215 atf2-phospho-thr69-71-transcription-factor-assay-kit Activating Transcription Factor 2 kits measuring measurement assays tf activating DNA-binding proteins bZIP octameric cyclic AMP-responsive elements CRE promoter regions genes mediates mediation DNA damage controls phosphorylation/activation inflammatory cytokines UV irradiation alkylating compounds cells cellular stressors pThr69,71 Thr69 Thr71 JNK/p38 homodimers heterodimers ATF/CREB Fos Fra2 c-Jun CREB ATF1 cycles control drug resistance apoptosis tumorigenesis insulin biosynthesis non-radioactive detection detecting nuclear extracts ELISA enzyme-linked immunosorbent assay double-stranded dsDNA colorimetric 69 71 phosphorylated 21.891220492215
13502 Bnc 1 Polyclonal Antibody - 2009-09-09 0E-12 bnc-1-polyclonal-antibody antibodies transcription factor WB western blots immunoblotting blotting zing finger protein phosphorylation Ser537 Ser541 Bnc1 Bnc-1 TFs 0E-12
10004985 Caylin-1 - >98% 2005-09-09 14.983093922652 caylin-1 caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes 14.983093922652
10005002 Caylin-2 - >98% 2004-07-12 13.664419889502 caylin-2 apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 13.664419889502
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 2.659116022099 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology 2.659116022099
10009753 ChREBP DBD Western Ready Control - 2007-05-03 2.261740331491 chrebp-dbd-western-ready-control Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams Beuren Syndrome Chromosome Region 14 WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology 2.261740331491
13505 HIF-2α Polyclonal Antibody - 2009-07-31 24.885497237569 hif-2-polyclonal-antibody Hypoxia Inducible Factor-2α antibodies HIF2 HIFs ARNT hpoxias factors WB blots western immunoblotting blotting 24.885497237569
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 45.398432320442 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 45.398432320442
10010184 NF-κB (p50) Western Ready Control - Whole cell lysate 2007-07-19 47.071057616416 nf-b-p50-western-ready-control Nuclear Factor-κB (p50); NF-κB1 western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals 47.071057616416
13751 NF-κB (p65) NLS Polyclonal Antibody - 2010-02-11 24.958658247829 nf-b-p65-nls-polyclonal-antibody Nuclear Factor-κB (p65) Nuclear Localization Signal NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies 24.958658247829
10004806 p53 Monoclonal Antibody (Clone BP53-12) - 2004-06-17 8.119675329104 p53-monoclonal-antibody-clone-bp53-12 proteins WB western blots blotting antibodies antisera antiserum DNA anti-oncogenic apoptosis cancers p53 apoptotic antioncogenic flow cytometry immunocytochemistry ICC IHC immunohistochemistry transcription factors cellular stress damage hypoxia shock guardian of the genome special:month specialdiscount:15 specialstart:2008-01-01 specialend:2008-01-31 immunoblotting FC 8.119675329104
10005291 p53 Product Pack - 2004-09-08 20.094964190710 p53-product-pack DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs 20.094964190710
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 28.164267955801 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 28.164267955801
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 21.181080417433 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 21.181080417433
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 61.004459352801 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 61.004459352801
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 19.116820135051 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 19.116820135051
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.494211172498 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.494211172498
10009568 PPARδ Western Ready Control - 2007-02-02 5.079270718232 ppar-western-ready-control Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity 5.079270718232
63520 PRIMA-1 5608-24-2 >95% 23.216282557221 prima-1 DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic cancers 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one 23.216282557221
10008841 Propylpyrazole Triol 263717-53-9 >98% 2007-01-25 78.562078729281 propylpyrazole-triol PPT 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology 78.562078729281
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 15.195226519336 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 15.195226519336
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?